Zoetis Inc. (NYSE: ZTS), a global leader in animal health, has announced the appointment of Ester Banque as the new Executive Vice President and President of U.S. Operations, effective July 10, 2023. Ms. Banque, a seasoned executive with over three decades of experience in health sciences at leading pharmaceutical firms, will join the Zoetis Executive team and directly report to CEO Kristin Peck.
“We’re thrilled to have Ester Banque leading our U.S. operations,” stated Kristin Peck, CEO of Zoetis. “Ester’s wealth of diverse, international experience, her leadership of top-performing teams, and her track record of driving above-market growth caught our attention. She’s a purpose-driven leader who will contribute significantly to Zoetis’ long-term sustainable growth.”
In her new role, Ms. Banque will manage the company’s U.S. commercial operations, focusing on expanding key franchises and paving the way for future innovations, all while providing outstanding service to companion animal and livestock customers.
Expressing her excitement, Ms. Banque said, “I’m proud to join Zoetis, an organization built on a purpose-driven culture, innovative pipelines, and high-performing teams. This new challenge will enable me to enhance my dedication to healthcare and further Zoetis’ mission to nurture our world by advancing care for animals. I am eager to contribute to Zoetis’ leadership in animal health and seize opportunities to impact our customers, colleagues, and communities positively.”
As Ms. Banque assumes her role, William (“Chip”) Dorsey, who served as the interim Head of U.S. Operations since February 2023, will continue his finance leadership role and assist Ms. Banque during her transition period. “On behalf of the Zoetis Executive Team, I want to express our gratitude to Chip for his valuable leadership over the past five months,” said Ms. Peck.
Image provided by Zoetis